Intranasal Drug Delivery

Global Market Trajectory & Analytics

MCP-1795

EXECUTIVE ENGAGEMENTS

POOL

13024
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1563
Interactions with Platform & by Email

PARTICIPANTS

391
Unique # Participated

VALIDATIONS

81
Responses Validated*

COMPANIES

77
Responses Validated*
* Login for a full stack data experience

DATE

JUL 2021

TABLES

213

PAGES

459

EDITION

15

PRICE

USD 5600

CODE

MCP-1795


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Global Intranasal Drug Delivery Market to Reach $71.3 Billion by 2026

As a direct result of technological advancements and increasing awareness among physicians and patients, a number of drug delivery options, including implantable, injectable, ocular, nasal, pulmonary, topical, transdermal, and transmucosal, are available to patients and care providers. The mode of delivering drugs to the target area of the patient body plays a decisive role in the effectiveness of the therapy. Pulmonary and nasal are the most popular approaches for drug delivery, owing to the ease of administration, particularly for patients requiring long-term therapy, improvement in quality of life of patients, the improved efficacy and bioavailability of administered drugs, lower risk of drug overdose, and easier compliance with stringent pharmaceutical regulations.

Nasal drug delivery route is suitable for systematic drug delivery, needleless vaccination, and for drug candidates with low oral absorption or vulnerable to first-pass effect in the human body. Intranasal drug delivery is a method involving the administration of drugs through the nasal cavity to produce a systemic or local therapeutic activity, with the exceptional vascular structure of the human nose making it suitable for administering small molecule drugs and biologics, and highly effective for treating local infections, and acute and chronic allergies. A plethora of local anesthetics, antibiotics, antihistamines, bronchodilators, calcium, corticosteroids, decongestant sprays, pain relief drugs, snuffs, supplements, vasoconstrictors and other drugs are administered through the intranasal route for chronic and acute treatments. Intranasal drugs are primarily administered in the form of ointments, sprays, powders, gels, and drops for treating allergic infections, analgesics, osteoporosis, vaccinations, pain management, anxiety, depression, and sexual dysfunction, among others.

Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$49.5 Billion in the year 2020, is projected to reach a revised size of US$71.3 Billion by 2026, growing at a CAGR of 6.2% over the analysis period. Liquid Delivery Devices, one of the segments analyzed in the report, is projected to grow at a 5.8% CAGR to reach US$31.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Powder Delivery Devices segment is readjusted to a revised 7% CAGR for the next 7-year period. This segment currently accounts for a 31.5% share of the global Intranasal Drug Delivery market.

The U.S. Market is Estimated at $21.9 Billion in 2021, While China is Forecast to Reach $5.7 Billion by 2026

The Intranasal Drug Delivery market in the U.S. is estimated at US$21.9 Billion in the year 2021. The country currently accounts for a 42.05% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$5.7 Billion in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR while Rest of European market (as defined in the study) will reach US$6.1 Billion by the close of the analysis period.

North America represents the leading global market for intranasal drug delivery, driven by the growing prevalence of respiratory disorders, such as asthma and COPD; the high adoption of drug delivery technique in healthcare institutions; and the growing affinity of patients for affordable generic drugs. Technological developments are among the major factors driving the growth of the US drug delivery industry. The US drug delivery market has recorded significant developments in the past few years, and the search for new technologies represent a perennial effort aimed at achieving incremental benefits. In addition to scientific advancements, other factors and issues such as availability of financial support, changing scientific policies, therapeutic protocols, government regulations, and market forces have a bearing on the drug delivery market.

Europe represents the second largest market for intranasal drug delivery, trailed by the Asia-Pacific. The European market is expected to showcase fast growth fueled by the rising prevalence of chronic illnesses targeted for intranasal therapeutics, the growing markets for geriatric care, pediatric care, and home healthcare. Emerging countries in Asia, the Middle East and Latin America, are expected to spearhead the growth of the global intranasal drug delivery market by virtue of the large pool of target patients, relatively stronger GDP growth, improving public and private healthcare infrastructure, increasing healthcare spending, and increasing penetration of medical insurance. The Asia-Pacific, led by countries such as India and China, is expected to exhibit strong growth through the burgeoning population, rising per capita incomes, increasing patient awareness about the benefits of intranasal drugs, and increasing investment from drug companies.

Pressurized Metered Dose Inhalers Segment to Reach $12 Billion by 2026

In the global Pressurized Metered Dose Inhalers segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$7 Billion in the year 2020 will reach a projected size of US$10.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$837.6 Million by the year 2026, while Latin America will expand at a 7.5% CAGR through the analysis period.

SELECT PLAYERS

AptarGroup, Inc.; AstraZeneca Plc.; Becton Dickinson and Company; GlaxoSmithKline Plc.; Johnson & Johnson Inc.; Merck & Co., Inc.; Nemera; Novartis AG; OptiNose US Inc.; Pfizer, Inc.

SEGMENTS

» Product Type (Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers, Other Product Types) » Application (Respiratory Disorders, Neurological Disorders, Pain Management, Other Applications)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
Promising Intranasal Vaccines to Nip COVID-19 Virus at Point of Entry
Influencer Market Insights
World Market Trajectories
Intranasal Drug Delivery: A Prelude
EXHIBIT: Leading Indications and APIs Amenable to Nasal Drug Delivery
Regional Market Analysis
Why Nasal Application is Garnering Notable Attention for Drug Delivery
Limitations of Intranasal Drug Delivery
Overview of the Traditional Drug Administration Routes, Molecular Weight Capabilities, and Dosage Range
Drug Delivery Pathways Related to the Nasal Cavity
Systemic delivery and Local Delivery Routes
Differences between Systemic Delivery and Local Effects
Challenges Involved In Formulating Nasal Drugs
Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier
Nose-to-Brain Drug Delivery: An Evolving Area of Interest
Factors Inhibiting Nose-to-Brain Transportation of Drugs
Bioavailability: An Important Facet of Intranasal Drug Delivery
Traditional Vs. Advanced Intranasal Drug Formulation Types
Type of Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application
Select FDA-Approved Nasal Products Compound (Trade Name) Indication Dosage Form Year
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rise in Prevalence of COPD Drives Opportunities
EXHIBIT: Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
Pharmaceutical and Medical Device Companies Vie to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients
EXHIBIT: Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries
The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
Intranasal Corticosteroids : A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease
Select Intranasal Corticosteroid Brands for Adult and Pediatric Usage
Manufacturers Focus on Improved Nasal Delivery Platforms
Controlled Release Technology is the Buzz Word
Research on Nanocarrier-Based Intranasal Drug Delivery Systems Picks Up Pace
Potential Role in Treatment and Management of Coronavirus Infection
Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight
Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era
EXHIBIT: Top Nasal Inhalers, Sprays, and Drops Brands in the US (2019): Percentage Share Breakdown of Dollar Sales
Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications
Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery
Intranasal Therapeutics Delivery: A High Potential Method for Treating CNS Diseases
Researchers Develop Nasal Spray Treatment for Parkinson’s Disease
Future Opportunities in CNS Space
Intranasal Delivery of Stem Cells: A Primary Strategy for Treatment of CNS Disorders
Intranasal Delivery of Stem Cells: Limitations
EXHIBIT 10: Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
Intranasal Delivery of Peptide-Based Pharmaceuticals
Select Protein, Peptide & Non-Peptide Drugs Available as Nasal Spray Solutions in the Marketplace
Select List of Nasal Biologics Available in the Market
Benefits of Bi-Directional Nasal Drug Delivery
Rise in Interest in Preservative-free Nasal Spray Formulations
Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Appendix: List of Select Intranasal Drugs in Phase III Clinical Trials
List of Select Intranasal Drugs for Pain Management in Phase III Clinical Trials
Select Intranasal Drugs for Cancer in Phase III Clinical Trials
Select Intranasal Drugs for Diabetes in Phase III Clinical Trials
Select Intranasal Drugs for Nasal Polyps in Phase III Clinical Trials
Select Intranasal Drugs for Depression in Phase III Clinical Trials
Select Intranasal Drugs for Chronic Sinusitis in Phase III Clinical Trials
Select Intranasal Drugs for Migraine in Phase III Clinical Trials
Intranasal Drugs for Allergic Rhinitis in Phase III Clinical Trials
Select Intranasal Drugs for Diabetes Mellitus in Phase III Clinical Trials
Select Intranasal Drugs for Covid-19 in Phase III Clinical Trials
Select Intranasal Drugs for Covid-19 in Phase III Clinical Trials
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2021 & 2027
World Current & Future Analysis for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Liquid Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
World Current & Future Analysis for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Powder Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
World Current & Future Analysis for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Pressurized Metered Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
World Current & Future Analysis for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Respiratory Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
World Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
World Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
World 11-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2021 & 2027
UNITED STATES
USA Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
USA 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
USA Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
USA 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
CANADA
Canada Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Canada 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Canada Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Canada 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
JAPAN
Japan Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Japan 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Japan Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Japan 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
CHINA
China Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
China 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
China Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
China 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
EUROPE
Europe Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Europe 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2021 & 2027
Europe Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Europe 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Europe Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Europe 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
FRANCE
France Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
France 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
France Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
France 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
GERMANY
Germany Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Germany 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Germany Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Germany 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
ITALY
Italy Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Italy 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Italy Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Italy 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
UK 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
UK Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
UK 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
SPAIN
Spain Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Spain 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Spain Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Spain 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
RUSSIA
Russia Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Russia 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Russia Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Russia 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Rest of Europe 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Rest of Europe Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Rest of Europe 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2021 & 2027
Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
AUSTRALIA
Australia Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Australia 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Australia Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Australia 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
INDIA
India Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
India 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
India Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
India 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
South Korea 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
South Korea Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
South Korea 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Rest of Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Rest of Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Rest of Asia-Pacific 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Latin America 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2021 & 2027
Latin America Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Latin America 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Latin America Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Latin America 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
ARGENTINA
Argentina Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Argentina 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Argentina Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Argentina 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
BRAZIL
Brazil Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Brazil 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Brazil Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Brazil 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
MEXICO
Mexico Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Mexico 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Mexico Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Mexico 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Rest of Latin America 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Rest of Latin America Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Rest of Latin America 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Middle East 11-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2016, 2021 & 2027
Middle East Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Middle East 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Middle East Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Middle East 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
IRAN
Iran Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Iran 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Iran Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Iran 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
ISRAEL
Israel Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Israel 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Israel Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Israel 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Saudi Arabia 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Saudi Arabia Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Saudi Arabia 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
UAE 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
UAE Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
UAE 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Rest of Middle East 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Rest of Middle East Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Rest of Middle East 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
AFRICA
Africa Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Africa 11-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2021 & 2027
Africa Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2019 and % CAGR
Africa 11-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2021 & 2027
Total Companies Profiled: 77

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com